title: RETRACTED: Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway.
abstract: This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy).
  
  This article has been retracted at the request of the Editor-in-Chief.
  
  This article shows significant data duplication and overlap with Liu, Weihua, et al., Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. European Journal of Pharmacology. 2010 Jul 25;638(1-3):150-5 (https://doi.org/10.1016/j.ejphar.2010.04.033) without adequate referencing. Although there is a slight difference in the methodology section regarding alloxan-induced diabetes models in the two articles, there is a clear overlap between Table 2 of Lan, Tian, et al., (2010); and Tables 1 and 2 of Liu, Weihua, et al. (2010). The two manuscripts were submitted from the same laboratory in the same year.
authors.affiliation: Sun Yat-sen University, Guangzhou, China.
authors.forename: Tian
authors.initials: T
authors.lastname: Lan
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Shen
authors.forename: Peiqing
authors.initials: P
authors.lastname: Liu
authors.forename: Weihua
authors.initials: W
authors.lastname: Liu
authors.forename: Suowen
authors.initials: S
authors.lastname: Xu
authors.forename: Xi
authors.initials: X
authors.lastname: Xie
authors.forename: Qin
authors.initials: Q
authors.lastname: Jiang
authors.forename: Wenyuan
authors.initials: W
authors.lastname: Li
authors.forename: Heqing
authors.initials: H
authors.lastname: Huang
mesh_terms: D000419:Albuminuria / Q000473:pathology; D000818:Animals; D001599:Berberine / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000473:pathology; D003921:Diabetes Mellitus, Experimental / Q000473:pathology; D003928:Diabetic Nephropathies / Q000473:pathology; D005947:Glucose / Q000378:metabolism; D007668:Kidney / Q000378:metabolism / Q000473:pathology*; D008246:Lysophospholipids; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D017853:Phosphotransferases (Alcohol Group Acceptor); D011897:Random Allocation; D015398:Signal Transduction / Q000187:drug effects; D013110:Sphingosine / Q000031:analogs & derivatives; D053773:Transforming Growth Factor beta1; D000099157:Sphingosine Kinase
chemical_list: D001599:Berberine; D005947:Glucose; D008246:Lysophospholipids; D017853:Phosphotransferases (Alcohol Group Acceptor); D013110:Sphingosine; D053773:Transforming Growth Factor beta1; D000099157:Sphingosine Kinase; C060506:sphingosine 1-phosphate